
Berlincleve Pharmaceuticals LLP
About Berlincleve Pharmaceuticals LLP
Data last updated:
Berlincleve Pharmaceuticals LLP is a limited liability partnership (LLP) based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 May 2019 and has been in existence for over 7 years.
The LLP is registered with the Registrar of Companies (ROC), Bangalore, under LLPIN AAP-1822.
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Mohammed Sameem Abdul Salim and Safeer Ahmad.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at #677 1st Floor Suite# 788 13th Cross Sector – 1 Hsr Layout, Bangalore, Karnataka, India – 560102.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address#677 1st Floor Suite# 788 13th Cross Sector – 1 Hsr Layout, Bangalore, Karnataka, India – 560102
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Berlincleve Pharmaceuticals LLP FY 2025 filings available
Financial Statement Summary of Berlincleve Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Berlincleve Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Berlincleve Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Berlincleve Pharmaceuticals LLP
Berlincleve Pharmaceuticals has 3 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammed Sameem Abdul Salim | Designated Partner | 30 May 2019 | 7 Years 4 Months | Current |
| Safeer Ahmad | Designated Partner | 03 May 2019 | 7 Years 5 Months | Current |
| Sanufar Nazar Also directs: Butonlab Private Limited | Designated Partner | 03 May 2019 | 7 Years 5 Months | Current |
Charges & Borrowings of Berlincleve Pharmaceuticals LLP
Berlincleve Pharmaceuticals LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Berlincleve Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Berlincleve Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Berlincleve Pharmaceuticals LLP
Berlincleve Pharmaceuticals LLP has 4 designated partner changes on record since 2019: 3 appointments and 1 cessation. The latest: Mohammed Sameem Abdul Salim was appointed as Designated Partner on 30 May 2019.
Credit Ratings, Litigation & Regulatory Alerts for Berlincleve Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Berlincleve Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Berlincleve Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Berlincleve Pharmaceuticals LLP
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Berlincleve Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Berlincleve Pharmaceuticals LLP
Berlincleve Pharmaceuticals is an active limited liability partnership based in Bangalore, Karnataka, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 May 2019 (7+ years old) and is registered under LLPIN AAP-1822.
Berlincleve Pharmaceuticals has 3 current designated partners:
- Mohammed Sameem Abdul Salim - Designated Partner
- Safeer Ahmad - Designated Partner
- Sanufar Nazar - Designated Partner
The LLPIN (Limited Liability Partnership Identification Number) of Berlincleve Pharmaceuticals is AAP-1822. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Berlincleve Pharmaceuticals was incorporated on 03 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Bangalore.
Mohammed Sameem Abdul Salim was appointed as Designated Partner on 30 May 2019. Mohammed Sameem Abdul Salim ceased to be Partner on 29 May 2019. Safeer Ahmad was appointed as Designated Partner on 03 May 2019. Berlincleve Pharmaceuticals has 4 designated partner changes on record in total.
The registered office of Berlincleve Pharmaceuticals is at #677 1st Floor Suite# 788 13th Cross Sector – 1 Hsr Layout, Bangalore, Karnataka, India – 560102.
The total obligation of contribution is ₹1 Lakh.
Berlincleve Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Berlincleve Pharmaceuticals can be reached at its registered office: #677 1st Floor Suite# 788 13th Cross Sector – 1 Hsr Layout, Bangalore, Karnataka, India – 560102.
Berlincleve Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Bangalore.